BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8523563)

  • 1. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.
    Karczewski MK; Strebel K
    J Virol; 1996 Jan; 70(1):494-507. PubMed ID: 8523563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure.
    Henzler T; Harmache A; Herrmann H; Spring H; Suzan M; Audoly G; Panek T; Bosch V
    J Gen Virol; 2001 Mar; 82(Pt 3):561-573. PubMed ID: 11172097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
    J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function.
    Simon JH; Miller DL; Fouchier RA; Malim MH
    Virology; 1998 Sep; 248(2):182-7. PubMed ID: 9721227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
    J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.
    Fouchier RA; Simon JH; Jaffe AB; Malim MH
    J Virol; 1996 Dec; 70(12):8263-9. PubMed ID: 8970945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
    Liu B; Yu X; Luo K; Yu Y; Yu XF
    J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.
    Madani N; Kabat D
    J Virol; 2000 Jul; 74(13):5982-7. PubMed ID: 10846079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.
    Khan MA; Akari H; Kao S; Aberham C; Davis D; Buckler-White A; Strebel K
    J Virol; 2002 Sep; 76(18):9112-23. PubMed ID: 12186895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.
    Dettenhofer M; Yu XF
    J Virol; 1999 Feb; 73(2):1460-7. PubMed ID: 9882352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells.
    Bouyac M; Rey F; Nascimbeni M; Courcoul M; Sire J; Blanc D; Clavel F; Vigne R; Spire B
    J Virol; 1997 Mar; 71(3):2473-7. PubMed ID: 9032385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells.
    Simon JH; Fouchier RA; Southerling TE; Guerra CB; Grant CK; Malim MH
    J Virol; 1997 Jul; 71(7):5259-67. PubMed ID: 9188594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Vif in human immunodeficiency virus type 1 reverse transcription.
    Goncalves J; Korin Y; Zack J; Gabuzda D
    J Virol; 1996 Dec; 70(12):8701-9. PubMed ID: 8970997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.
    Kao S; Akari H; Khan MA; Dettenhofer M; Yu XF; Strebel K
    J Virol; 2003 Jan; 77(2):1131-40. PubMed ID: 12502829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.
    Ochsenbauer C; Wilk T; Bosch V
    J Gen Virol; 1997 Mar; 78 ( Pt 3)():627-35. PubMed ID: 9049414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
    Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
    J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Vif during HIV-1 infection: interaction with novel host cellular factors.
    Lake JA; Carr J; Feng F; Mundy L; Burrell C; Li P
    J Clin Virol; 2003 Feb; 26(2):143-52. PubMed ID: 12600646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
    D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
    J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.